MDS:icMDS

Uma Borate1, Kelly Pugh1, Allyson Waller1

  • 1Division of Hematology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, The Ohio State University, Columbus, OH.

Blood
|March 27, 2025
PubMed
概括

骨髓质疏松症候群 (MDS) 临床试验的限制性资格标准通常不必要地将患者排除在外. 这项研究发现,各阶段的标准相似,很少与药物安全性保持一致,阻碍了招生.